US5040677A - Container for storage and distribution of a skin wound dressing - Google Patents

Container for storage and distribution of a skin wound dressing Download PDF

Info

Publication number
US5040677A
US5040677A US07/532,965 US53296590A US5040677A US 5040677 A US5040677 A US 5040677A US 53296590 A US53296590 A US 53296590A US 5040677 A US5040677 A US 5040677A
Authority
US
United States
Prior art keywords
package
sheet
planar
support surface
cultured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/532,965
Inventor
Ross A. Tubo
Richard Odessey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Biosurface Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosurface Technology Inc filed Critical Biosurface Technology Inc
Assigned to BIOSURFACE TECHNOLOGY, INC. reassignment BIOSURFACE TECHNOLOGY, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: ODESSEY, RICHARD, TUBO, ROSS A.
Priority to US07/532,965 priority Critical patent/US5040677A/en
Priority to PCT/US1991/003538 priority patent/WO1991018575A1/en
Priority to AT91911160T priority patent/ATE165234T1/en
Priority to EP91911160A priority patent/EP0532628B1/en
Priority to DE69129301T priority patent/DE69129301T2/en
Priority to ES91911160T priority patent/ES2117643T3/en
Priority to JP3510632A priority patent/JP2733800B2/en
Priority to DK91911160T priority patent/DK0532628T3/en
Publication of US5040677A publication Critical patent/US5040677A/en
Application granted granted Critical
Assigned to GENZYME CORPORATION reassignment GENZYME CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOSURFACE TECHNOLOGY, INC.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F15/00Auxiliary appliances for wound dressings; Dispensing containers for dressings or bandages
    • A61F15/001Packages or dispensers for bandages, cotton balls, drapes, dressings, gauze, gowns, sheets, sponges, swabsticks or towels

Definitions

  • This invention relates to the field of tissue storage and distribution.
  • cultured grafts are delivered directly to the operating room at the burn center or hospital for application to the patient.
  • Each graft package consists of a layer of cultured epithelium attached with surgical clips to a backing of petrolatum gauze.
  • Each cultured graft is approximately 25 cm 2 in size and is individually packaged in a shallow dish containing a small amount of serum-free, sodium bicarbonate buffered medium which contains antibiotics.
  • Multiple dishes containing the grafts are shipped in a sterilized gas-tight container. The transport container must be gas tight, since the sodium bicarbonate buffered medium requires 10% CO 2 for maintenance of proper pH.
  • grafts as skin wound dressings also presents other practical difficulties.
  • the tensile strength of the grafts is such that they often cannot support their own weight and tear if suspended by an edge. For this reason, the grafts are attached to gauze to allow easier handling. Once a graft has folded over upon itself it is very difficult to restore to its original planar configuration, and essentially impossible without the gauze backing. Handling of the grafts should be kept to a minimum since handling causes a significant, measurable reduction in cell viability.
  • the object of this invention is to provide a specially designed container for storage and distribution of a skin wound dressing which allows a minimum of handling and easy removal so that maximal viability of the dressing is maintained prior to application to skin wounds arising from burns and other injuries.
  • the object is achieved by the provision and use of a gas-tight sealable container for individual grafts.
  • the containers, once sealed, are gas-tight and spill proof.
  • the grafts are stored with minimal air space, shear forces that tear the graft away from its backing are reduced.
  • the invention is embodied as an article of manufacture useful in the storage and distribution of a skin wound dressing comprising a housing or package containing a cultured epithelial sheet.
  • the housing defines a support surface for a planar, cohesive sheet of cultured epithelial cells capable of replication upon application to a skin wound.
  • the housing is sealed with a cover to define an enclosed space for the epithelial cell sheet. The seal can be broken and the cover removed so that the planar sheet of epithelial cells can be removed intact and with minimal mechanical stress by lifting to peel the sheet away perpendicular to the support surface.
  • the housing may contain an epithelial cell storage medium, which may be saline or a culture medium, or it may contain a cryoprotectant.
  • the planar sheet of epithelial cells typically is less than about 10 cells thick, and is partially differentiated.
  • the sheet may be attached releasably to a backing sheet or substrate disposed between the planar sheet of cells and the support surface of the container.
  • the cells are preferably keratinocytes, and the backing sheet is preferably petrolatum gauze.
  • the container may have side walls and an integral gripping tab for manually holding the container and facilitating removal of the cover.
  • FIG. 1 is a top plan view of the article of manufacture of the invention showing an epithelial sheet enclosed within a housing;
  • FIG. 2 is a cross-sectional view of the product of FIG. 1 taken at lines 2--2;
  • FIG. 3 illustrates the manual removal of the cover from the housing of the product of the invention
  • FIG. 4 illustrates the manual removal of the wound dressing from the housing
  • FIG. 5 illustrates the transfer of the wound dressing from the housing to the patient.
  • This invention relates to a container for the storage and distribution of a skin wound dressing.
  • the container facilitates storage and subsequent transport and application of intact, living, cultured epithelial cell sheets from a central manufacturing facility to the site of surgery to treat skin wounds arising from burns and other injuries.
  • Cultured human epithelial cell sheets can function as permanent autograft material for repair of skin wounds. As temporary allograft material, the sheets are also a highly effective burn wound dressing and can Promote healing of chronic skin ulcers and split-thickness graft donor sites.
  • the sheets may be produced using a culture system developed by Rheinwald and Green, wherein epithelial cells divide rapidly on the surface of tissue culture dishes or flasks and ultimately form a confluent, modestly stratified sheet of tightly interconnected cells. Confluent epithelial cell cultures can be released as coherent cell sheets by treatment with an enzyme, such as dispase, then stapled to gauze impregnated with petroleum jelly such as Vaseline®, transported to the operating room, and applied to the patient.
  • an enzyme such as dispase
  • petroleum jelly such as Vaseline®
  • the cell cultures are used to prepare grafts within 2 days of reaching confluence.
  • the supernatant medium is aspirated from the culture flask and the cell sheet is cut to produce two equal areas.
  • Forty ml of Dispase II (Boehringer Mannheim) at a final concentration of 2.5 mg/ml (approximately 1.2U/ml) is added to the flask, which is then put into a sterile plastic bag and incubated at 37° C. in a humidified atmosphere of 10% CO 2 in air.
  • the cultured grafts comprise a layered sheet of epithelial cells less than about 10 cells thick. The sheet typically is moderately stratified into partially differentiated layers including a superficial layer and an underlying germinative layer that ultimately will be placed in contact with the surface of the wound.
  • FIGS. 1 and 2 illustrate a package 10 comprising a housing 20 and a cover 21 which together define a space 22 containing a skin wound dressing designated generally at 30.
  • the housing 20 comprises side walls 16 connected at their top edge to a sealing portion 17 and at their bottom edge by a dressing support surface 18.
  • a gripping tab 19 is integral with and extends outwardly from side wall 16.
  • the cover 21 is sealed to the housing 20 at sealing portions 17 to provide the liquid-impervious space 22 about the wound dressing 30.
  • the cover 21 may be attached to the sealing portion 17 by heat, adhesive, or other means known in the art.
  • the space 22 may contain saline or a culture medium, either or both of which may be supplemented with one or more cryoprotectants.
  • Skin wound dressing 30 comprises a cultured, cohesive sheet of epithelial cells 10 disposed upon an adhesive substrate sheet or backing 13, so that the germinative layer of the graft 10 is facing upwards toward the cover 21.
  • Graft 10 is releasably attached to substrate sheet 13 by clips 14.
  • Substrate sheet 13 preferably comprises petrolatum gauze. It facilitates manipulation of graft 10 prior to application to a skin wound and thereafter serves as a removable dressing overlying the graft 10 on the skin wound.
  • Housing 20 may be fabricated, for example, by vacuum forming a sheet of thermoplastic material, Preferably an optically clear plastic. Polyethylene terephthalate glycol is the currently preferred material.
  • Cover 21 most preferably comprises polyolefin, and is sealed to the housing by means of a heat sealable resin. The package is sterilized Prior to use by, for example, exposure to 2.5 to 3.0 megarads of gamma radiation. The package may be used for storage or transport of frozen or non-frozen epithelial cell sheets. Details of the currently preferred freezing and thawing protocols are disclosed in copending U.S. application Ser. No. 07/533,385 filed on the same day as this application, the disclosure of which is incorporated herein by reference.
  • FIGS. 3, 4, and 5 illustrate use of the product of the invention.
  • the cover 21 is grasped between the thumb and forefinger of one hand as shown.
  • a tab 19 is grasped and the cover 21 is removed by manually separating it from sealing engagement with sealing portions 17 of housing 20 to permit full exposure of skin wound dressing 30.
  • the dressing 30 is gently lifted upwardly perpendicularly away from or "peeled" from support surface 18 by gripping substrate sheet 13 with a forecepts 25.
  • This mode of separation of the dressing from the package minimizes shear forces on the fragile grafts 10, and serves to maintain optimal efficacy as a graft.
  • FIG. 5 shows topical application of a cultured graft 10.
  • dressing 30 is inverted so that adhesive substrate sheet 13 is topmost and the germinative layer of sheet 10 faces downward. In this position dressing 30 is transferred to the wound, such that the germinative layer of the graft lies against the wound, protected exteriorly by adhesive substrate or backing sheet 13.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Position Input By Displaying (AREA)
  • Prostheses (AREA)

Abstract

Disclosed is a container for the storage and distribution of a cultured epithelial, generally planar, living, skin wound dressing that allows the dressing to be gently removed by lifting perpendicular to a support surface in the container. The design minimizes handling of the graft dressing thereby promoting cell viability.

Description

BACKGROUND OF THE INVENTION
This invention relates to the field of tissue storage and distribution.
It has been a priority in the medical community to develop a skin wound dressing which will encourage new growth while preventing fluid loss and infection following skin wounds from burns, ulceration, or surgical excision. Traditional bandages and dressings fail to protect large-scale wounds adequately, therefore various alternatives have been developed. Among these are split- and full-thickness grafts of cadaver or porcine skin, and human allografts and autografts. Most have proved unsatisfactory since all but autografts eventually are rejected by the body in the absence of immunosuppressive therapy. Autografts are useful in small areas, but use of conventional autografting technique is not practical for massive burn injury involving large body surface areas. Cultured sheets of epithelial cells for use as skin wound dressings are now available commercially from Biosurface Technology, Inc. of Cambridge, Mass.
Currently, cultured grafts are delivered directly to the operating room at the burn center or hospital for application to the patient. Each graft package consists of a layer of cultured epithelium attached with surgical clips to a backing of petrolatum gauze. Each cultured graft is approximately 25 cm2 in size and is individually packaged in a shallow dish containing a small amount of serum-free, sodium bicarbonate buffered medium which contains antibiotics. Multiple dishes containing the grafts are shipped in a sterilized gas-tight container. The transport container must be gas tight, since the sodium bicarbonate buffered medium requires 10% CO2 for maintenance of proper pH.
Problems that have been encountered with the current transport system include spillage of medium from shallow tissue culture dishes into the sterilized transport box, loss of the gas tight nature of the box during transit, resulting in grafts being maintained in medium at basic pH for an unknown period of time, and detachment of the epithelium from the vaseline gauze backing, due to shear forces of medium sloshing around during transit.
The use of these grafts as skin wound dressings also presents other practical difficulties. The tensile strength of the grafts is such that they often cannot support their own weight and tear if suspended by an edge. For this reason, the grafts are attached to gauze to allow easier handling. Once a graft has folded over upon itself it is very difficult to restore to its original planar configuration, and essentially impossible without the gauze backing. Handling of the grafts should be kept to a minimum since handling causes a significant, measurable reduction in cell viability.
The object of this invention is to provide a specially designed container for storage and distribution of a skin wound dressing which allows a minimum of handling and easy removal so that maximal viability of the dressing is maintained prior to application to skin wounds arising from burns and other injuries. The object is achieved by the provision and use of a gas-tight sealable container for individual grafts. The containers, once sealed, are gas-tight and spill proof. In addition, since the grafts are stored with minimal air space, shear forces that tear the graft away from its backing are reduced.
SUMMARY OF THE INVENTION
The invention is embodied as an article of manufacture useful in the storage and distribution of a skin wound dressing comprising a housing or package containing a cultured epithelial sheet. The housing defines a support surface for a planar, cohesive sheet of cultured epithelial cells capable of replication upon application to a skin wound. The housing is sealed with a cover to define an enclosed space for the epithelial cell sheet. The seal can be broken and the cover removed so that the planar sheet of epithelial cells can be removed intact and with minimal mechanical stress by lifting to peel the sheet away perpendicular to the support surface. The housing may contain an epithelial cell storage medium, which may be saline or a culture medium, or it may contain a cryoprotectant. The planar sheet of epithelial cells typically is less than about 10 cells thick, and is partially differentiated. The sheet may be attached releasably to a backing sheet or substrate disposed between the planar sheet of cells and the support surface of the container. The cells are preferably keratinocytes, and the backing sheet is preferably petrolatum gauze. The container may have side walls and an integral gripping tab for manually holding the container and facilitating removal of the cover.
BRIEF DESCRIPTION OF THE DRAWINGS
For a fuller understanding of the nature, objects, and features of the invention, reference should be made to the following detailed description and accompanying drawings, wherein:
FIG. 1 is a top plan view of the article of manufacture of the invention showing an epithelial sheet enclosed within a housing;
FIG. 2 is a cross-sectional view of the product of FIG. 1 taken at lines 2--2;
FIG. 3 illustrates the manual removal of the cover from the housing of the product of the invention;
FIG. 4 illustrates the manual removal of the wound dressing from the housing; and
FIG. 5 illustrates the transfer of the wound dressing from the housing to the patient.
Like reference characters in the respective drawn figures indicate corresponding parts.
DESCRIPTION
This invention relates to a container for the storage and distribution of a skin wound dressing. The container facilitates storage and subsequent transport and application of intact, living, cultured epithelial cell sheets from a central manufacturing facility to the site of surgery to treat skin wounds arising from burns and other injuries.
Cultured human epithelial cell sheets can function as permanent autograft material for repair of skin wounds. As temporary allograft material, the sheets are also a highly effective burn wound dressing and can Promote healing of chronic skin ulcers and split-thickness graft donor sites. The sheets may be produced using a culture system developed by Rheinwald and Green, wherein epithelial cells divide rapidly on the surface of tissue culture dishes or flasks and ultimately form a confluent, modestly stratified sheet of tightly interconnected cells. Confluent epithelial cell cultures can be released as coherent cell sheets by treatment with an enzyme, such as dispase, then stapled to gauze impregnated with petroleum jelly such as Vaseline®, transported to the operating room, and applied to the patient. For a detailed disclosure of methods for producing the cultured epithelial sheets, see U.S. Pat. No. 4,016,036, 4,304,866, and 4,456,687, the disclosures of which are incorporated herein by reference.
The cell cultures are used to prepare grafts within 2 days of reaching confluence. The supernatant medium is aspirated from the culture flask and the cell sheet is cut to produce two equal areas. Forty ml of Dispase II (Boehringer Mannheim) at a final concentration of 2.5 mg/ml (approximately 1.2U/ml) is added to the flask, which is then put into a sterile plastic bag and incubated at 37° C. in a humidified atmosphere of 10% CO2 in air. The cultured grafts comprise a layered sheet of epithelial cells less than about 10 cells thick. The sheet typically is moderately stratified into partially differentiated layers including a superficial layer and an underlying germinative layer that ultimately will be placed in contact with the surface of the wound.
FIGS. 1 and 2 illustrate a package 10 comprising a housing 20 and a cover 21 which together define a space 22 containing a skin wound dressing designated generally at 30. The housing 20 comprises side walls 16 connected at their top edge to a sealing portion 17 and at their bottom edge by a dressing support surface 18. A gripping tab 19 is integral with and extends outwardly from side wall 16. The cover 21 is sealed to the housing 20 at sealing portions 17 to provide the liquid-impervious space 22 about the wound dressing 30. The cover 21 may be attached to the sealing portion 17 by heat, adhesive, or other means known in the art. The space 22 may contain saline or a culture medium, either or both of which may be supplemented with one or more cryoprotectants.
Skin wound dressing 30 comprises a cultured, cohesive sheet of epithelial cells 10 disposed upon an adhesive substrate sheet or backing 13, so that the germinative layer of the graft 10 is facing upwards toward the cover 21. Graft 10 is releasably attached to substrate sheet 13 by clips 14. Substrate sheet 13 preferably comprises petrolatum gauze. It facilitates manipulation of graft 10 prior to application to a skin wound and thereafter serves as a removable dressing overlying the graft 10 on the skin wound.
Housing 20 may be fabricated, for example, by vacuum forming a sheet of thermoplastic material, Preferably an optically clear plastic. Polyethylene terephthalate glycol is the currently preferred material. Cover 21 most preferably comprises polyolefin, and is sealed to the housing by means of a heat sealable resin. The package is sterilized Prior to use by, for example, exposure to 2.5 to 3.0 megarads of gamma radiation. The package may be used for storage or transport of frozen or non-frozen epithelial cell sheets. Details of the currently preferred freezing and thawing protocols are disclosed in copending U.S. application Ser. No. 07/533,385 filed on the same day as this application, the disclosure of which is incorporated herein by reference.
FIGS. 3, 4, and 5 illustrate use of the product of the invention. The cover 21 is grasped between the thumb and forefinger of one hand as shown. At the same time, a tab 19 is grasped and the cover 21 is removed by manually separating it from sealing engagement with sealing portions 17 of housing 20 to permit full exposure of skin wound dressing 30. As shown in FIG. 4, the dressing 30 is gently lifted upwardly perpendicularly away from or "peeled" from support surface 18 by gripping substrate sheet 13 with a forecepts 25. This mode of separation of the dressing from the package minimizes shear forces on the fragile grafts 10, and serves to maintain optimal efficacy as a graft. FIG. 5 shows topical application of a cultured graft 10. Following remove from housing 20, dressing 30 is inverted so that adhesive substrate sheet 13 is topmost and the germinative layer of sheet 10 faces downward. In this position dressing 30 is transferred to the wound, such that the germinative layer of the graft lies against the wound, protected exteriorly by adhesive substrate or backing sheet 13.
The above has been offered for illustrative purposes only, and is not intended to limit the scope of the invention of this application, which is defined in the claims below.

Claims (14)

What is claimed is:
1. A skin wound dressing package comprising:
a first package member defining a sealing surface;
a second package member sealingly engaged with said sealing surface, said second package member defining, together with said first package member, a liquid impervious enclosure, one of said first and second package members comprising a dressing support surface, one of said first and second package members comprising a recess and the other comprising a sheet-like member,
a wound dressing comprising a planar, cultured, cohesive, sheet of epithelial cells capable of replication upon application to a skin wound supported within said enclosure on said support surface in an epithelial cell storage medium; and
means for separating said first and second package members to break said sealing engagement and to expose substantially the entire area of said planar cultured sheet, thereby to permit removal of said planar cultured sheet from said housing intact by lifting to peel said sheet away perpendicular to said support surface.
2. The package of claim 1 wherein said storage medium is saline.
3. The package of claim 1, wherein said storage medium is an epithelial cell culture medium.
4. The article of claim 1 wherein said planar sheet is less than about 10 cells thick and defines a germinative layer for contact with a skin wound.
5. The article of claim 4 further comprising an adhesive substrate sheet disposed between said support surface and said planar sheet wherein said germinative layer faces away from said substrate sheet.
6. A skin wound dressing package comprising:
a first package member defining a sealing surface;
a second package member sealingly engaged with said sealing surface, said second package member defining, together with said first package member, a liquid impervious enclosure, one of said first and second package members comprising a dressing support surface, one of said first and second package members comprising a recess and the other a sheet-like member, and
a wound dressing comprising a planar, cultured, cohesive sheet of epithelial cells capable of replication upon application to a skin wound and comprising a germinative layer for contact with said skin wound facing away from said support surface, said dressing being supported within said enclosure parallel to said support surface on an adhesive substrate sheet disposed between said support surface and said cultured sheet; and
means for separating said first and second package members to break said sealing engagement and to expose substantially the entire area of said planar cultured sheet, thereby to permit removal of said cultured sheet from said housing intact by lifting to peel said cultured sheet away perpendicular to said support surface.
7. The package of claim 1 or 6 comprising a cryoprotectant disposed within said enclosure wherein said sheet is frozen.
8. A skin wound dressing package comprising:
a first package member defining a sealing surface;
a second package member sealingly engaged with said sealing surface, said second package member defining, together with said first package member, a liquid impervious enclosure, one of said first and second package members comprising a dressing support service, one of said first and second package members comprising a recess and the other a sheet-like member, and
a wound dressing comprising a planar, cultured, cohesive frozen sheet of epithelial cells capable of replication after thawing upon application to a skin wound, supported within said enclosure parallel to said support service in a cryoprotectant; and
means for separating said first and second package member to break said sealing engagement and to expose substantially the entire area of said planar sheet, thereby to permit removal of said planar sheet from said housing intact by lifting to peel said planar sheet away perpendicular to said support surface.
9. The package of claim 5, 6 or 8 wherein said substrate sheet is petrolatum gauze.
10. The package of claim 5, 6 or 8 wherein said substrate sheet is releasably attached to said planar sheet, whereby said substrate sheet is useful as a removable covering for said planar sheet when applied to a skin wound.
11. The package of claim 1, 6, or 8 wherein said housing and cover means comprise transparent polymeric material.
12. The package of claim 1, 6, or 8 further comprising a gripping tab integral with one of said first and second package members and extending outwardly in a plane parallel to said support surface.
13. The package of claim 1, 6 or 8 wherein said epithelial cells are keratinocytes.
14. The package of claim 1, 6 or 8 wherein said sealing surface and said cover means are adhesively bound.
US07/532,965 1990-06-04 1990-06-04 Container for storage and distribution of a skin wound dressing Expired - Fee Related US5040677A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US07/532,965 US5040677A (en) 1990-06-04 1990-06-04 Container for storage and distribution of a skin wound dressing
DE69129301T DE69129301T2 (en) 1990-06-04 1991-05-20 CONTAINER FOR STORING AND DISTRIBUTING A SKIN Wound Dressing
AT91911160T ATE165234T1 (en) 1990-06-04 1991-05-20 CONTAINER FOR STORING AND DISTRIBUTING A SKIN WOUND DRESSING
EP91911160A EP0532628B1 (en) 1990-06-04 1991-05-20 Container for storage and distribution of a skin wound dressing
PCT/US1991/003538 WO1991018575A1 (en) 1990-06-04 1991-05-20 Container for storage and distribution of a skin wound dressing
ES91911160T ES2117643T3 (en) 1990-06-04 1991-05-20 CONTAINER FOR STORAGE AND DISTRIBUTION OF A DRESSING FOR SKIN WOUNDS.
JP3510632A JP2733800B2 (en) 1990-06-04 1991-05-20 Skin wound dressing package
DK91911160T DK0532628T3 (en) 1990-06-04 1991-05-20 Container for storage and distribution of skin ulcer dressings

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/532,965 US5040677A (en) 1990-06-04 1990-06-04 Container for storage and distribution of a skin wound dressing

Publications (1)

Publication Number Publication Date
US5040677A true US5040677A (en) 1991-08-20

Family

ID=24123926

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/532,965 Expired - Fee Related US5040677A (en) 1990-06-04 1990-06-04 Container for storage and distribution of a skin wound dressing

Country Status (8)

Country Link
US (1) US5040677A (en)
EP (1) EP0532628B1 (en)
JP (1) JP2733800B2 (en)
AT (1) ATE165234T1 (en)
DE (1) DE69129301T2 (en)
DK (1) DK0532628T3 (en)
ES (1) ES2117643T3 (en)
WO (1) WO1991018575A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008776A1 (en) * 1991-11-01 1993-05-13 Culture Technology, Inc. Cultured skin graft carrier
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
WO1999037233A1 (en) 1998-01-23 1999-07-29 Reprogenesis, Inc. Method and apparatus for aseptically packaging and dispensing live material
US6053318A (en) * 1999-07-07 2000-04-25 Petterson; Tor Package for housing a self-adhesive bandage
WO2001008630A2 (en) * 1999-07-29 2001-02-08 Reprogenesis, Inc. Sterile packaging of live material with improved storage characteristics
EP1085081A1 (en) * 1999-09-17 2001-03-21 Laboratoires Genevrier Method for the transport of cells and grafts
US20020049613A1 (en) * 2000-10-20 2002-04-25 Arthrex, Inc. Method of selling procedure specific allografts and associated instrumentation
US20040167489A1 (en) * 2003-02-14 2004-08-26 Kellenberger Stanley R. Compact absorbent article
US6854599B2 (en) * 2001-03-06 2005-02-15 Musculoskeletal Transplant Foundation Packaging system for frozen allograft tissue forms
EP1516532A1 (en) * 1995-01-30 2005-03-23 Organogenesis Inc. Package design for cryopreservation and storage of cultured tissue equivalents
US20140034536A1 (en) * 2012-08-06 2014-02-06 Carefusion 303, Inc. Adhesive dressing integrated packaging
US10582994B2 (en) 2018-03-06 2020-03-10 Musculoskeletal Transplant Foundation Implant packaging assembly
US10695157B2 (en) 2017-01-10 2020-06-30 Musculoskeletal Transplant Foundation Packaging system for tissue grafts
USD954993S1 (en) 2020-06-17 2022-06-14 Musculoskeletal Transplant Foundation Tissue graft retainer
US11375710B2 (en) 2017-01-10 2022-07-05 Musculoskeletal Transplant Foundation Packaging system for tissue grafts

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681740A (en) * 1995-06-05 1997-10-28 Cytotherapeutics, Inc. Apparatus and method for storage and transporation of bioartificial organs
DE19828671C2 (en) * 1998-06-26 2002-12-05 Univ Ludwigs Albert Container with cryopreserved biological material
WO2003024213A1 (en) * 2001-09-17 2003-03-27 Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata Case for the protection and the transportation of epidermis or skin grafts cultivated in vitro from a skin graft cut from a donor
JP4572258B2 (en) * 2009-01-09 2010-11-04 株式会社 ジャパン・ティッシュ・エンジニアリング Cultured cell sheet packaging
WO2010119692A1 (en) 2009-04-16 2010-10-21 Keio University Transplantation device
JP2015133934A (en) * 2014-01-17 2015-07-27 大日本印刷株式会社 Cell sheet package and film container
IL254644B (en) * 2017-09-24 2021-06-30 Reddress Ltd Wound dressing device, assembly and method
IL254636A0 (en) * 2017-09-24 2017-11-30 Reddress Ltd Assembly and method for the preparation of a wound dressing
CA3156941A1 (en) * 2019-11-01 2021-05-06 Neurotech Usa, Inc. System, apparatuses, devices, and methods for an analyte diffusive implantable device

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2649392A (en) * 1950-03-30 1953-08-18 Kraft Foods Co Method of forming seal in synthetic plastic packages
US2990948A (en) * 1958-04-04 1961-07-04 Johnson & Johnson Sterile package
US3403776A (en) * 1967-03-21 1968-10-01 Johnson & Johnson Sterile surgical package
DE2136166A1 (en) * 1971-03-11 1972-09-14 Sada, Pietro, Rom Process for the production, preservation and distribution of frozen preparations from natural organic substances that have cosmetic properties
US3717244A (en) * 1971-02-10 1973-02-20 Pratt Mfg Corp Package with easy opening dust flap and method of manufacturing the same
US3903882A (en) * 1974-04-19 1975-09-09 American Cyanamid Co Composite dressing
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
FR2436084A1 (en) * 1978-09-13 1980-04-11 Manudo Plastics dishes for storage and use of bacteriological culture gels - with ancillary covers which may be sealed or ventilated
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4456687A (en) * 1978-11-16 1984-06-26 President And Fellows Of Harvard College Agents for promoting growth of epithelial cells
US4557381A (en) * 1983-09-09 1985-12-10 Alba-Waldensian, Inc. Wrap for impregnated dressing
WO1986003976A1 (en) * 1984-12-27 1986-07-17 Baxter Travenol Laboratories, Inc. Tissue storage system
US4630448A (en) * 1985-10-25 1986-12-23 Baxter Travenol Laboratories, Inc. Container for storing solid living tissue portions
US4681839A (en) * 1982-09-23 1987-07-21 Swartz Mitchell R Systems to preserve living tissue
US4687476A (en) * 1983-07-14 1987-08-18 Eric Pailin Topical dressings

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042109A (en) * 1976-01-21 1977-08-16 C. R. Bard, Inc. Medical procedure package
US4049121A (en) * 1976-07-14 1977-09-20 Baxter Travenol Laboratories, Inc. Moisture detection system for a sterile package
US4206844A (en) * 1977-01-04 1980-06-10 Toppan Printing Co., Ltd. Package for a sterilized material
US4299819A (en) * 1979-01-02 1981-11-10 Sloan-Kettering Institute For Cancer Research Process for treating burn victims
FR2589165B1 (en) * 1985-10-24 1989-01-20 Inst Nat Sante Rech Med PROCESS FOR OBTAINING A HUMAN CULTURE EPITHELIUM, EPITHELIAL FABRIC OBTAINED AND ITS APPLICATION TO ALLOGRAFTS
US4913700A (en) * 1987-11-04 1990-04-03 L. Vad Technology, Inc. Culture and transport assembly for percutaneous access device

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2649392A (en) * 1950-03-30 1953-08-18 Kraft Foods Co Method of forming seal in synthetic plastic packages
US2990948A (en) * 1958-04-04 1961-07-04 Johnson & Johnson Sterile package
US3403776A (en) * 1967-03-21 1968-10-01 Johnson & Johnson Sterile surgical package
US3717244A (en) * 1971-02-10 1973-02-20 Pratt Mfg Corp Package with easy opening dust flap and method of manufacturing the same
DE2136166A1 (en) * 1971-03-11 1972-09-14 Sada, Pietro, Rom Process for the production, preservation and distribution of frozen preparations from natural organic substances that have cosmetic properties
US3903882A (en) * 1974-04-19 1975-09-09 American Cyanamid Co Composite dressing
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
FR2436084A1 (en) * 1978-09-13 1980-04-11 Manudo Plastics dishes for storage and use of bacteriological culture gels - with ancillary covers which may be sealed or ventilated
US4456687A (en) * 1978-11-16 1984-06-26 President And Fellows Of Harvard College Agents for promoting growth of epithelial cells
US4304866A (en) * 1979-11-14 1981-12-08 Massachusetts Institute Of Technology Transplantable sheets of living keratinous tissue
US4681839A (en) * 1982-09-23 1987-07-21 Swartz Mitchell R Systems to preserve living tissue
US4687476A (en) * 1983-07-14 1987-08-18 Eric Pailin Topical dressings
US4557381A (en) * 1983-09-09 1985-12-10 Alba-Waldensian, Inc. Wrap for impregnated dressing
WO1986003976A1 (en) * 1984-12-27 1986-07-17 Baxter Travenol Laboratories, Inc. Tissue storage system
US4630448A (en) * 1985-10-25 1986-12-23 Baxter Travenol Laboratories, Inc. Container for storing solid living tissue portions

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BioSurface Technology, Inc., "Cultured Autograft Service Orientation Manual", (1988).
BioSurface Technology, Inc., "Epithelial Cell Culturing Service", Mar. 1988.
BioSurface Technology, Inc., Cultured Autograft Service Orientation Manual , (1988). *
BioSurface Technology, Inc., Epithelial Cell Culturing Service , Mar. 1988. *
F. Kasten & D. Yip, "A Simple Device and Procedure for Successful Freezing of Cells in Liquid Nitrogen Vapor", Methods in Cell Biology, vol. 14, 165-179 (1976).
F. Kasten & D. Yip, A Simple Device and Procedure for Successful Freezing of Cells in Liquid Nitrogen Vapor , Methods in Cell Biology, vol. 14, 165 179 (1976). *
H. Green, "Terminal Differentiation of Cultured Human Epidermal Cells", Cell, vol. 11, 405-416, Jun. 1977.
H. Green, Terminal Differentiation of Cultured Human Epidermal Cells , Cell, vol. 11, 405 416, Jun. 1977. *
R. Blondet, M. A. Gibert Thevenin, C. Pierre & A. Ehrsam, Skin Preservation by Programmed Freezing , British Journal of Plastic Surgery, vol. 35, pp. 530 536 (1982). *
R. Blondet, M. A. Gibert-Thevenin, C. Pierre & A. Ehrsam, "Skin Preservation by Programmed Freezing", British Journal of Plastic Surgery, vol. 35, pp. 530-536 (1982).
S. Randolph May, R. Guttman, & J. Wainwright, "Cryopreservation of Skin Using an Insulated Heat Sink Box Stored at -70° C.", Cryobiology, vol. 22, pp. 205-214 (1985).
S. Randolph May, R. Guttman, & J. Wainwright, Cryopreservation of Skin Using an Insulated Heat Sink Box Stored at 70 C. , Cryobiology, vol. 22, pp. 205 214 (1985). *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008776A1 (en) * 1991-11-01 1993-05-13 Culture Technology, Inc. Cultured skin graft carrier
EP1516532A1 (en) * 1995-01-30 2005-03-23 Organogenesis Inc. Package design for cryopreservation and storage of cultured tissue equivalents
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
WO1999037233A1 (en) 1998-01-23 1999-07-29 Reprogenesis, Inc. Method and apparatus for aseptically packaging and dispensing live material
US6053318A (en) * 1999-07-07 2000-04-25 Petterson; Tor Package for housing a self-adhesive bandage
WO2001002270A1 (en) * 1999-07-07 2001-01-11 Tor Petterson Package for housing a self-adhesive bandage
WO2001008630A2 (en) * 1999-07-29 2001-02-08 Reprogenesis, Inc. Sterile packaging of live material with improved storage characteristics
WO2001008630A3 (en) * 1999-07-29 2012-01-12 Reprogenesis, Inc. Sterile packaging of live material with improved storage characteristics
FR2798668A1 (en) * 1999-09-17 2001-03-23 Genevrier Lab NEW PROCESS FOR THE TRANSPORT OF CELLS AND THE GRAFTS THUS CARRIED OUT
EP1085081A1 (en) * 1999-09-17 2001-03-21 Laboratoires Genevrier Method for the transport of cells and grafts
US20020049613A1 (en) * 2000-10-20 2002-04-25 Arthrex, Inc. Method of selling procedure specific allografts and associated instrumentation
US20090248592A1 (en) * 2000-10-20 2009-10-01 Reinhold Schmieding Method of selling procedure specific allografts and associated instrumentation
US7548865B2 (en) * 2000-10-20 2009-06-16 Arthrex, Inc. Method of selling procedure specific allografts and associated instrumentation
US6854599B2 (en) * 2001-03-06 2005-02-15 Musculoskeletal Transplant Foundation Packaging system for frozen allograft tissue forms
US20040167489A1 (en) * 2003-02-14 2004-08-26 Kellenberger Stanley R. Compact absorbent article
US20040168947A1 (en) * 2003-02-14 2004-09-02 Mcdonald Duane L. Packaging with easy open feature
US20040172002A1 (en) * 2003-02-14 2004-09-02 Nelson Denise J. Package enclosing a single disposable absorbent article
US20040167490A1 (en) * 2003-02-14 2004-08-26 Nelson Denise J. Methods of folding disposable absorbent articles
US8118166B2 (en) * 2003-02-14 2012-02-21 Kimberly-Clark Worldwide, Inc. Packaging with easy open feature
US8893887B2 (en) * 2012-08-06 2014-11-25 Carefusion 303, Inc. Adhesive dressing integrated packaging
US20140034536A1 (en) * 2012-08-06 2014-02-06 Carefusion 303, Inc. Adhesive dressing integrated packaging
AU2013299935B2 (en) * 2012-08-06 2017-08-17 Carefusion 303, Inc. Adhesive dressing integrated packaging
US10695157B2 (en) 2017-01-10 2020-06-30 Musculoskeletal Transplant Foundation Packaging system for tissue grafts
US11375710B2 (en) 2017-01-10 2022-07-05 Musculoskeletal Transplant Foundation Packaging system for tissue grafts
US10582994B2 (en) 2018-03-06 2020-03-10 Musculoskeletal Transplant Foundation Implant packaging assembly
US10828141B2 (en) 2018-03-06 2020-11-10 Musculoskeletal Transplant Foundation Implant packaging assembly
USD954993S1 (en) 2020-06-17 2022-06-14 Musculoskeletal Transplant Foundation Tissue graft retainer
USD1001311S1 (en) 2020-06-17 2023-10-10 Musculoskeletal Transplant Foundation Tissue graft retainer

Also Published As

Publication number Publication date
DE69129301T2 (en) 1998-11-12
DK0532628T3 (en) 1998-10-05
JPH05508565A (en) 1993-12-02
ES2117643T3 (en) 1998-08-16
DE69129301D1 (en) 1998-05-28
JP2733800B2 (en) 1998-03-30
EP0532628B1 (en) 1998-04-22
WO1991018575A1 (en) 1991-12-12
ATE165234T1 (en) 1998-05-15
EP0532628A1 (en) 1993-03-24

Similar Documents

Publication Publication Date Title
US5040677A (en) Container for storage and distribution of a skin wound dressing
US5476443A (en) Wound dressing product containing a porous layer
US5693332A (en) Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
JP3766934B2 (en) Methods and apparatus for treating tissue damage
US5712137A (en) Laminate of a culture substrate on a carrier for producing an apertured wound dressing
US20030219469A1 (en) Environmental control device for tissue treatment
WO2003008285A1 (en) Device and method for hydrating and rehydrating orthopedic graft materials
JP4749155B2 (en) Cultured cell sheet packaging
US20220330542A1 (en) Tissue container systems
WO1992010217A1 (en) Wound dressings and processes for manufacture thereof
JP2004187518A (en) Cultured cell sheet package and sheet sandwiching member
CA2011111C (en) Cool storage of cultured epithelial sheets
JP2003070460A (en) Backing material for membrane tissue and method for storing/transporting the membrane tissue using the same
WO1997006835A1 (en) Cell culture products
US20240245050A1 (en) Tissue container systems
WO1993008776A1 (en) Cultured skin graft carrier
US20220287298A1 (en) Tissue container systems

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIOSURFACE TECHNOLOGY, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:TUBO, ROSS A.;ODESSEY, RICHARD;REEL/FRAME:005339/0289

Effective date: 19900529

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: GENZYME CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOSURFACE TECHNOLOGY, INC.;REEL/FRAME:007833/0032

Effective date: 19960207

FEPP Fee payment procedure

Free format text: PAT HLDR NO LONGER CLAIMS SMALL ENT STAT AS SMALL BUSINESS (ORIGINAL EVENT CODE: LSM2); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 20030820

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362